Daniel Dietrick
Urology · Towson, MDNPI 1528015914
Payments from drug & device makers
Across 235 payments — averaging $27.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SN Holdings, LLC$2K
- Johnson & Johnson$766
- Astellas Pharma US Inc$397
- Sumitomo Pharma America, Inc.$389
- Bayer$315
- Urovant Sciences Inc$274
- plus $2K from 33 others
What the payments were for
- Travel & lodging$1,23419%
- Food & beverage$5,28281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SN Holdings, LLC | 7 | $1,941 |
| Johnson & Johnson | 41 | $766 |
| Astellas Pharma US Inc | 22 | $397 |
| Sumitomo Pharma America, Inc. | 15 | $389 |
| Bayer | 16 | $315 |
| Urovant Sciences Inc | 20 | $274 |
| Endo Pharmaceuticals Inc. | 11 | $232 |
| Myovant Sciences Inc. | 13 | $223 |
| Pfizer | 14 | $190 |
| AbbVie(2 entities) | 11 | $180 |
| Boston Scientific | 3 | $133 |
| Tolmar Pharmaceuticals, Inc. | 6 | $122 |
| Antares Pharma, Inc. | 6 | $115 |
| Tolmar, Inc. | 4 | $110 |
| Blue Earth Diagnostics | 5 | $108 |
| Merck | 5 | $105 |
| Dendreon Pharmaceuticals LLC | 4 | $102 |
| Medtronic | 1 | $95 |
| Intuitive Surgical | 1 | $91 |
| Sun Pharmaceutical Industries Inc. | 2 | $85 |
| Urogen Pharma, Inc. | 1 | $76 |
| Clarus Therapeutics Inc. | 3 | $47 |
| Halozyme Inc | 2 | $47 |
| Accord Healthcare, Inc. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 3 | $39 |
| Neotract Inc. | 1 | $35 |
| Novartis | 2 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Convatec Inc. | 2 | $29 |
| Mission Pharmacal Company | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $20 |
| Rochester Medical Corporation | 1 | $19 |
| Ambu Inc. | 1 | $19 |
| Acacia Pharma Inc | 1 | $15 |
| Metuchen Pharmaceuticals | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Coloplast | 1 | $12 |
| Urogpo LLC | 2 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,516 in reported general payments places this provider in the 55th percentile of 274 urology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 17 | $14,370 |
| Tamsulosin Hcl | 68 | $1,807 |
| Finasteride | 55 | $714 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $389 | $14,37017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 274 urology providers in Maryland.
Other urology in Towson
- Jonathan RubensteinTowson$171K
- Meagan DunneTowson$31K
- Matthew AllawayCumberland$20.6M
- Ronald TutroneBaltimore$18.1M
- Mohamad AllafBaltimore$7.1M
- Max KatesBaltimore$1000K
- Benjamin LowentrittBaltimore$994K
- Rian DicksteinHanover$750K
- Laura GiustoOwings Mills$628K
- Kenneth LangerBaltimore$610K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.